Core Viewpoint - Guangzhou Bibete Pharmaceutical Co., Ltd. has completed the registration change and received a new business license following the approval of changes to its registered capital, company type, and amendments to its articles of association [1]. Group 1: Company Changes - The company held its second board meeting on November 11, 2025, and the first extraordinary general meeting of shareholders on November 28, 2025, to approve the proposal for changes in registered capital and company type [1]. - The company has received a new business license from the Huangpu District Market Supervision Administration of Guangzhou, reflecting the changes made [1]. Group 2: Company Information - The updated business license indicates the following details: - Unified Social Credit Code: 91440101589519277H - Name: Guangzhou Bibete Pharmaceutical Co., Ltd. - Type: Joint-stock company (foreign investment, listed) - Address: 25 A-3 Building, Yaying Stone Road, Science City, High-tech Industrial Development Zone, Guangzhou - Legal Representative: Qian Changgeng - Registered Capital: 450,366,570 RMB - Establishment Date: January 19, 2012 - Business Scope: Research and experimental development [1].
广州必贝特医药股份有限公司关于完成工商变更登记并换发营业执照的公告